Caracemide
Caracemide (NSC-253272) is a ribonucleotide reductase inhibitor active against E. coli. This mechanism has prompted its investigation as a potential antineoplastic agent in both in vitro and in vivo cancer research studies.
Product Specifications
CAS Number
81424-67-1
Product Name Alternative
CNS, coli, Caracemide, DNASynthesis, DNA/RNA Synthesis, DNA Synthesis, Bacterial, anticancer, Escherichia, hydroxamic, Inhibitor, methylisocyanate, MIC, NSC253272, NSC-253272, inhibit, NSC 253272, toxicity, RNA Synthesis, RNASynthesis, ribonucleotide, ribonucleotide reductase (RR), reductase
Field of Research
Cell Biology, Infectious Disease & Virology, Molecular Biology
Purity
98.81% (May vary between batches)
Solubility
DMSO:95 mg/mL (502.19 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (17.44 mM)
Smiles
CNC (=O) ON (C (C) =O) C (=O) NC
Molecular Formula
C6H11N3O4
Molecular Weight
189.17
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL310496V 500 µL Each
PEX12 Human shRNA Lentiviral Particle (Locus ID 5193)
Sign In for Pricing
View Details